Anbenitamab (KN026) is an anti-HER2 bispecific antibody independently developed by Alphamab Oncology using the proprietary Fc-based heterodimer bispecific platform technology called CRIB (Charge ...
TORONTO, Oct. 12, 2025 /CNW/ – PERTH, Australia – Oct. 13, 2025 – IsoEnergy Ltd. (“IsoEnergy”) (NYSE American: ISOU) (TSX: ISO) and Toro Energy Ltd. (“Toro”) (ASX: TOE) are pleased to announce ...